Concepedia

Is widespread screening for hepatitis C justified?

Ronald L. Koretz, Kexiong Lin, J. P. A. Ioannidis, Jeanne Lenzer

BMJ · 2015 · 52 citations · 43 references

DOI

Concepts

Abstract

Several organisations have recommended greatly expanded screening for hepatitis C infection. <b>Ronald Koretz and colleagues</b> are concerned that no study has tested whether this will lead to net clinical benefit or harm in screened populations

References

43

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Bart J. Veldt, Jordan J. Feld, Heiner Wedemeyer et al. · JAMA · 2012 · 1.5K citations · Full text

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations